Stifel analyst Justin Keywood lowered the firm’s price target on Quipt Home Medical (QIPT) to C$7 from C$7.50 and keeps a Buy rating on the shares.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QIPT:
- Quipt Home Medical price target lowered to $6 from $7 at Benchmark
- Quipt Home Medical Shows Strong 2024 Financial Growth
- Quipt Home Medical reports Q4 revenue $61.3M vs $59.6M last year
- Options Volatility and Implied Earnings Moves Today, December 16, 2024
- QIPT Earnings Report this Week: Is It a Buy, Ahead of Earnings?